Binding hotspots of BAZ2B bromodomain:histone interaction revealed by solution NMR driven docking by Ferguson, Fleur M. et al.
                                                              
University of Dundee
Binding hotspots of BAZ2B bromodomain
Ferguson, Fleur M.; Dias, David M.; Rodrigues, João P. G. L. M.; Wienk, Hans; Boelens, Rolf;
Bonvin, Alexandre M. J. J.; Abell, Chris; Ciulli, Alessio
Published in:
Biochemistry
DOI:
10.1021/bi500909d
Publication date:
2014
Document Version
Publisher's PDF, also known as Version of record
Link to publication in Discovery Research Portal
Citation for published version (APA):
Ferguson, F. M., Dias, D. M., Rodrigues, J. P. G. L. M., Wienk, H., Boelens, R., Bonvin, A. M. J. J., ... Ciulli, A.
(2014). Binding hotspots of BAZ2B bromodomain: histone interaction revealed by solution NMR driven docking.
Biochemistry, 53(42), 6706-6716. 10.1021/bi500909d
General rights
Copyright and moral rights for the publications made accessible in Discovery Research Portal are retained by the authors and/or other
copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with
these rights.
 • Users may download and print one copy of any publication from Discovery Research Portal for the purpose of private study or research.
 • You may not further distribute the material or use it for any profit-making activity or commercial gain.
 • You may freely distribute the URL identifying the publication in the public portal.
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 18. Mar. 2016
Binding Hotspots of BAZ2B Bromodomain: Histone Interaction
Revealed by Solution NMR Driven Docking
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ABSTRACT: Bromodomains are epigenetic reader domains, which have come under increasing scrutiny both from academic
and pharmaceutical research groups. Effective targeting of the BAZ2B bromodomain by small molecule inhibitors has been
recently reported, but no structural information is yet available on the interaction with its natural binding partner, acetylated
histone H3K14ac. We have assigned the BAZ2B bromodomain and studied its interaction with H3K14ac acetylated peptides by
NMR spectroscopy using both chemical shift perturbation (CSP) data and clean chemical exchange (CLEANEX-PM) NMR
experiments. The latter was used to characterize water molecules known to play an important role in mediating interactions.
Besides the anticipated Kac binding site, we consistently found the bromodomain BC loop as hotspots for the interaction. This
information was used to create a data-driven model for the complex using HADDOCK. Our findings provide both structure and
dynamics characterization that will be useful in the quest for potent and selective inhibitors to probe the function of the BAZ2B
bromodomain.
Bromodomains are epigenetic reader domains, whichrecognize acetylated lysines in a substrate-specific
manner.1 Bromodomain-containing proteins have recently
generated much interest from the scientific community due
to their roles in transcription, inflammation, and disease.2
Additionally, generation of potent, selective chemical probes for
the BET bromodomains has highlighted this family as tractable
targets for small molecule inhibition.3,4 The BAZ2B protein has
an unknown function but is homologous in overall domain
organization to the BAZ2A/TIP5 protein,5 the major subunit of
the transcriptional repressor complex NoRC. NoRC establishes
a heterochromatic state, preserving genome stability. The
complex has also been shown to silence rRNA genes.6 The
BAZ2A and B bromodomains share 57% sequence homology
and fall into bromodomain subfamily V.1
The BAZ2B bromodomain folds into four helices (αZ, αA,
αB, αC), connected by two loops (ZA and BC), forming a
typical bromodomain fold.1 It is known that acetyl lysine binds
in a pocket in the center of the four-helix bundle, flanked by the
two loops, and that this interaction is mediated by waters
occupying the bottom of the pocket (PDB 4NR97), Figure 1.
Previous studies by Philpott et al. based on histone peptide
arrays and isothermal titration calorimetry (ITC) characterized
histone H3K14ac as the binding partner of the BAZ2B
bromodomain.8 Although a structure of the BAZ2B bromodo-
main with free acetyl lysine bound is available (PDB 4NR9),
how the BAZ2B bromodomain specifically recognizes histone
H3 K14ac is still poorly understood as no structural
information has yet been reported on a protein−peptide
complex.
Received: July 24, 2014
Revised: September 25, 2014
Published: September 30, 2014
Article
pubs.acs.org/biochemistry
© 2014 American Chemical Society 6706 dx.doi.org/10.1021/bi500909d | Biochemistry 2014, 53, 6706−6716
Terms of Use CC-BY
Acetylated lysine alone is known to interact only very weakly
with the BAZ2B bromodomain, but it is necessary for the
interaction to occur.8 We therefore sought to identify and
characterize additional interactions contributing to the affinity
and specificity of histone H3 Kac14 peptide binding using a
combination of biophysical techniques, NMR spectroscopy,
and docking simulations. The resulting models were validated
with site-directed mutagenesis and peptide binding studies
using ITC.
■ EXPERIMENTAL PROCEDURES
Protein Expression. Escherichia coli rosetta competent cells
were transformed with a pNIC28 plasmid containing the
BAZ2B bromodomain (residues 1868−1972), which has
previously been described1 and used for protein expression.
15N and 15N, 13C- uniformly labeled BAZ2B bromodomains
were expressed in M9 medium9 with 1.5 g of 15NH4Cl (Sigma-
Aldrich) and 4.0 g of D-glucose or [U−13C6]-D-glucose (Sigma-
Aldrich) per liter as the sole nitrogen and carbon sources.
Colonies from freshly transformed cells were grown in 50 mL
of M9 medium containing kanamycin (50 μg/mL) at 37 °C
with 180 rpm shaking for 16 h. Start up cultures were diluted
and inoculated in fresh M9 medium (1 L), containing
kanamycin (50 μg/mL), with an initial optical densitiy
(OD600) of ∼0.15 and grown at 37 °C with 180 rpm shaking
to an optical density (OD600) of ∼0.8. At this point the
temperature was decreased to 18 °C, and once the system was
equilibrated protein expression was induced with 0.8 mM
isopropyl-β-D-thiogalactopyranoside (IPTG) for 18 h. The cells
were harvested by centrifugation (6000 rpm, 30 min, 4 °C)
using a Beckman Coulter Avanti J-20 XP centrifuge.
Protein Purification. Cell pellets were resuspended in lysis
buffer (50 mM HEPES, pH 7.5 at 25 °C, 500 mM NaCl, 5 mM
imidazole, 5% glycerol and 0.5 mM TCEP) in the presence of
protease inhibitor cocktail and lysed by passing through a
French press (three times) at 4 °C. The lysate was cleared by
centrifugation at (16000g, 1 h, 4 °C) and applied to a
HisTrapFF Column (GE Healthcare), equilibrated with lysis
buffer. Protein was eluted using a gradient elution of 5−300
mM imidazole. For labeled samples the hexa-histidine-tag was
removed by treatment with Tobacco Etch Virus protease (20:1
ratio) in the presence of 0.5 mM EDTA and 1 mM
dithiothreitol (DTT) at 4 °C overnight, and protease was
removed by running a second HisTrap column. Fractions from
chromatography were monitored by SDS-PAGE, using 16%
acrylamide gels stained with bromophenol blue. Protein was
concentrated and loaded onto Superdex 75 16/60 HiLoad gel
filtration column (GE Healthcare) at 4 °C equilibrated with 50
mM HEPES, pH 7.5, 500 mM NaCl, 5% glycerol, 0.5 mM
TCEP. Purified protein was concentrated using a Vivaspin-20
concentrator with a 10 000 Da MW cutoff (Vivascience). The
absorbance of protein (A280) samples was measured on a
Picodrop Microliter UV/vis spectrophotometer (ThermoScien-
tific). Protein concentrations were calculated using molar
extinction coefficient predicted using ProtPARAM.10 The MW
of the purified protein was determined using Nanospray-TOF
MS, performed on an ABI Q-STAR mass spectrometer. For
uniformly 15N labeled BAZ2B bromodomain, the expected MW
= 13768 Da, observed MW = 13752, corresponding to 91%
incorporation.
Mutagenesis. Site-directed mutagenesis was performed
using the QuikChange site-directed mutagenesis kit (Agilent).
DNA was purified using a QIAprep Spin kit (Qiagen) following
the manufacturer’s protocols. Plasmids were sequenced at
SourceBiosciences, Cambridge. The absorbance of DNA (A260)
samples was measured on a Picodrop Microliter UV/vis
spectrophotometer (ThermoScientific). DNA purity was
verified by measuring the A260/A280 ratio, and all DNA used
had A260/A280 > 1.7.
Differential Scanning Fluorimetry. Thermal Shift experi-
ments were performed using a Lightcycler480 (Roche).
Experiments were carried out using 10 μM protein in 50 mM
HEPES pH 7.5, 150 mM NaCl, 2.5x SyproOrange (Sigma-
Aldrich). Melting temperatures are reported as the average of
three measurements.
Isothermal Titration Calorimetry. All experiments were
carried out using an ITC200 microcalorimeter (GE Healthcare)
at 10 °C, unless otherwise stated, while stirring at 1000 rpm.
Experiments were carried out in 50 mM HEPES pH 7.5, 150
mM NaCl. Protein was buffer exchanged using a Pierce protein
desalting spin column (Fischer Scientific, UK). All titrations
were conducted using an initial injection of 0.4 μL followed by
19 identical injections of 2 μL at a rate of 2 s/μL. Data were
corrected for heats of dilution by subtracting the data from
independent titrations of ligand into buffer. Data were
processed using MicroCal Origin software.
Peptides were either ordered from LifeTein (CellTein) or
GenScript, or synthesized using standard Fmoc solid phase
peptide synthesis (see Supporting Information). Concentra-
tions were either determined using a Nanodrop spectropho-
tometer (Thermo Scientific) and the predicted extinction
coefficient (ProtPARAM), or by amino acid analysis.
Circular Dichroism Spectroscopy. Proteins were diluted
to 0.1 mg/mL in degassed CD buffer (10 mM HEPES, pH 7.4
at 25 °C). CD measurements from a buffer only sample were
subtracted from the protein CD measurements. CD experi-
ments were carried out on a Chirascan CD spectrometer
(Applied Photophysics) at 25 °C using 0.1 cm quartz cuvettes
(Hellma Analytics).
NMR Experiments. 15N/13C-labeled BAZ2B bromodomain
(1 mM) spectra were recorded at 298 K in 20 mM Tris-HCl,
pH 7.0 at 25 °C, 100 mM NaCl, 1 mM DTT, and 10% D2O.
Triple resonance, relaxation, small molecule and peptide
titration NMR spectra were recorded using a Bruker Avance
Figure 1. Structural features of the BAZ2B bromodomain. (A) X-ray
structure of BAZ2B showing conserved 4-helix fold. (B) Zoom in of
binding site occupied by free acetyl lysine and five conserved waters
(PDB ID 4NR9).
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III 600 spectrometer equipped with a 5 mm TXI
1H−13C/15N/2H Z-GRD probe.
BAZ2B bromodomain backbone resonance assignment was
performed using 2D [15N−1H]-HSQC, and 3D HNCO,
HN(CA)CO, CBCA(CO)NH, and HNCACB. These spectra
were processed using Bruker Topspin 2.1. Chemical shift
perturbations (CSPs) were calculated using the equation:
= Δ + Δ⎜ ⎟
⎛
⎝⎜
⎛
⎝
⎞
⎠
⎞
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In addition, signal intensity changes over the titration were
calculated relative to the peak corresponding to the C-terminus
(V1971) as an internal reference. A cutoff of 1 standard
deviation was used to determine significance of CSPs or
intensity changes.
Internal dynamics of BAZ2B bromodomain were obtained
using 15N-R1, 15N-R2, and 15N{1H}-heteronuclear NOE
relaxation values and were obtained as described previously.11
15N-R1 data were obtained from decaying peak intensities in a
randomized series of spectra recorded with relaxation delays of
10, 20, 40, 80, 160, 400, 1000, 2000, 4000, 6000, and 7000 ms.
R2-values were extracted from CPMG spectra recorded with
relaxation delays of 32, 64, 95, 127, 158, 190, 222, and 286 ms.
Signal intensities were fitted using Curvefit.12 Heteronuclear
NOEs were obtained using signal intensity ratios from
experiments with proton saturation of 5 s and without. For
model free analyses, errors in R1 and R2 values were estimated
to be 3% of the value, and for heteronuclear NOE an error of
0.05 was assumed. FAST-Modelfree13 was used to perform the
model-free analysis. Chemical shifts, relaxation rates, and
heteronuclear NOE values are deposited in BMRB accession
number 25105.
Molecular Dynamics. Molecular dynamics calculations
were performed using GROMACS v4.5.3.14 Starting coor-
dinates were obtained from the X-ray crystal structure of apo-
BAZ2B (PDB 3G0L) containing a total of 117 residues. Crystal
waters further than 5 Å from the Kac binding site were
removed. pKa calculations of residues were carried out using
PROPKA3.0 web server15 to estimate of the protonation states
of residues at pH 7.5. No residues were found to have
nonstandard protonation states, and the protein is uncharged at
this pH; therefore, no ions were added to the simulation water
box. The protein was solvated in an octahedral TIP3P water
box extending 1 nm from the edge of the protein. Minimization
was carried out using a steepest descent algorithm. Particle-
Mesh-Ewald (PME) summation was applied to treat long-range
interactions, and a cutoff of 0.9 nm was applied for nonbonded
interactions. A 0.2 ns equilibration with harmonic restraints was
carried out followed by a 225 ns production free MD
simulation, performed using the AMBER99SB-STAR-ILDN
force field16 with a time step of 2 fs.
HADDOCK Docking. HADDOCK is a data-driven docking
program tailored to model protein interactions using
experimental data as restraints. The protein-peptide docking
protocol requires specific adaptations to accommodate the
higher flexibility of the peptide molecule.17 The input peptide
ensemble consisted of two conformationsextended β-sheet
and U-turn−based on an observation of different crystallized
bromodomain−peptide complexes. PyMOL was used to build
the extended conformation peptide, using −139° for ϕ and
−135° for ψ dihedral angles. The U-turn conformation peptide
was taken from the NMR structure of the second
bromodomain of PB1 bound to H3K14ac histone peptide
(PDB ID 2KTB18). Unambiguous distance restraints were
generated from the Kac-bound crystal structure of BAZ2B
(PDB ID 4NR97) to anchor the acetyl group on the lysine side
chain in the binding site and restrain the interaction of a
conserved water molecule with Y1901. The protein active
residues were defined as those whose CSP values or peak
intensity decreases are more than 1 σ from the average. The
peptide was defined entirely as passive except for the acetyl
lysine residue, which was defined as active. All calculations were
run through the HADDOCK Web server19 (http://haddock.
science.uu.nl/services/HADDOCK), which implements ver-
sion 2.1 of the software. Each calculation generated 5000/400/
400 models for the different it0/it1/water refinement stages of
HADDOCK. The final 400 models were clustered based on
their interface-ligand RMSD using a cutoff of 5 Å. The final
overall score of each cluster is based on the four highest
HADDOCK scores of the models in that cluster.
■ RESULTS
BAZ2B Bromodomain Resonance Assignments. In
order to provide a practical structural tool for mapping ligands
in its binding site, we assigned the backbone amide protons of
the BAZ2B bromodomain by NMR spectroscopy. These
assignments enable high-throughput binding site validation of
small molecules or other known interacting partners (∼8 min
per 2D [15N−1H]-HSQC experiment).
The majority of signal intensities in the 2D [15N−1H]-HSQC
spectrum were assigned unambiguously (89% backbone amide
completeness, Figure 2A and Supplementary Table 1). Besides
the N-terminus (S1856 to S1867) only D1885 was missing,
yielding a total coverage of 99% of the structured protein. The
missing D1885 assignment might be due to resonance
overlapping. The secondary structure predicted with TALOS
+ is in overall agreement with the X-ray structure (PDB ID
3G0L) (Figure 2B−C). We observed significant differences in
signal intensity for some residues, for instance, D1946. This led
us to further investigate the BAZ2B bromodomain internal
dynamics using solution NMR.
Internal Dynamics of the BAZ2B Bromodomain.
Heteronuclear 15N relaxation R2/R1 ratios (Figure 3) reveal
not a completely homogeneous distribution across the
structured protein, which can be attributed to either internal
dynamics or overall tumbling anisotropy. Overall the values of
the heteronuclear NOEs fall predominantly in the range 0.7−
0.9, indicating a relatively rigid core. Three residues at the C-
terminus (K1970, V1971, and S1972) may undergo fast
internal dynamics, as indicated by reduced R2/R1 ratios and
[15N−1H]-heteronuclear NOE values (Figure 3A,B), suggesting
that this region may be unstructured in solution. Consistent
with this observation, residues 1971 and 1972 are not visible in
X-ray structures of this construct.
The rotational correlation time (τc) of a protein is dependent
on its size, shape, and dynamics in solution; hence this
parameter is used to gauge overall rotational motion
information. However, for nonspherical proteins the best
assessment of these motions can be modeled using an axially
symmetric tensor (characterized by diffusion constants around
the unique (D∥) and perpendicular (D⊥) axes). For BAZ2B, the
τc found was 10.86 ± 0.04 ns, being higher than the value
predicted with HYDRONMR20 (7.5 ns). To rule out the
possibility of dimerization or increased viscosity, we performed
diffusion-ordered spectroscopy (DOSY21), which confirmed
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the monomeric form of BAZ2B only, since it is diffusing in line
with its molecular weight (data not shown). Accordingly the
protein elutes as a single peak in size-exclusion chromatography
(Supplementary Figure 1, Supporting Information). The
slightly increased τc value is in agreement with what has been
observed for other proteins in this family (BRD4 BD2, 14.8
ns22). We suspect the value is higher than predicted because the
slightly extended unstructured N-terminal region of the protein
(residues S1856−S1867) influences the tumbling in solution.
The slight anisotropy of the axial symmetric rotational diffusion
tensor (D∥/D⊥ = 1.14) is consistent with the somewhat
elongated shape also found in the X-ray crystal structure (PDB
code 3G0L) and explains the trends in observed R1/R2 ratios
(Figure 3).
In order to separate the overall tumbling properties of the
BAZ2B bromodomain from its internal dynamics, model-free
analysis was performed with FAST-Modelfree,13 using the
standard combinations of contributions to internal motions
(i.e., (1) squared generalized order parameter S2, (2) S2 and
internal correlation time τi, (3) S
2 and slow conformational
exchange term Rex, (4) S
2 and τi and Rex, and (5) S
2 and τi and
extra order parameter for fast internal motions S2f). Most of the
residues fell in model 1 which indicates high rigidity of the
BAZ2B bromodomain in the ps−ns time scale. Few isolated
residues show either fast or slow dynamic propensity. Higher
values for τi, showing fast internal motions (ps−ns), are found
in residues in the ZA loop (A1886, F1889, and Y1901) and the
BC loop (D1946), along with C-terminal residue V1971
(Figure 3D). These regions depict values of τi on the order of 1
ns. Residues with slow exchange contributions (Rex), at around
3 Hz, are located in helices B and C and involve interhelical
contacts (F1929 to F1937 on helix B, A1953 to H1955 and
F1961 to D1967 on helix C) (Figure 3E).
Molecular Dynamics Simulations. Molecular dynamics
simulations were carried out to further assess the internal
dynamics of the BAZ2B bromodomain (see Supplementary
Figure 2 for RMSD plotted over the simulation). Throughout a
225 ns simulation all four helices remained stable, with the
root-mean-square fluctuation (RMSF) of the backbone atoms
below 0.1 nm for most residues (Figure 4B). Residues with a
high average RMSF over the simulation were clustered mostly
at the N-termini (unstructured region) and in the ZA loop,
with some additional residues undergoing fast dynamics also
detected in the BC loop and the turn joining the A and B
helices (Figure 4). This is in agreement with the NMR
dynamics analysis. Principle component analysis of the
simulation was conducted to examine correlated motions.
The first eigenvector of this analysis revealed a movement in
Figure 2. BAZ2B spectral assignment (A) 2D [15N−1H]-HSQC
showing the assignment of BAZ2B bromodomain backbone amide
peaks. (B) Comparison of the NMR secondary structure prediction to
that seen in the X-ray structure of this construct (PDB ID 3G0L). (C)
Secondary structure prediction using Talos+ (bars represent α helix
propensity).
Figure 3. Parameters describing internal dynamics for the assigned and
nonoverlapping residues of BAZ2B bromodomain. (A) 15N-R2/R1
ratios; (B) 15N{1H}-heteronuclear NOE values; (C) squared general
order parameters, S2; (D) fast (ns−ps) internal motions expressed as
internal correlation times, τi (ps); (E) slow (ms−μs) dynamics
expressed as exchange contribution to the line shape, Rex (Hz).
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the upper ZA loop away from the center of the four helix
bundle, widening the Kac binding site and reducing its
enclosure (Supplementary Figure 3).
Small Molecule HSQC Titration Monitored by
[15N−1H]-HSQC. In order to assess the utility of the assigned
spectra for mapping ligands to their binding site in the BAZ2B
bromodomain, we conducted a titration with Compound 1
(Figure 5B), a reported fragment hit, for which the structure in
complex with BAZ2B has been solved using X-ray crystallog-
raphy (PDB ID 4NRC7). Chemical shift perturbations (CSPs)
were observed in the BAZ2B [15N−1H]-HSQC spectrum for
the peaks of residues in direct contact with the titrated ligand
(e.g., F1889, Figure 5B). Additional CSPs were seen in residues
close to the fragment binding site (A1953, N1939, L1891),
(Figure 5A). Three residues (A1871, M1875, and F1929) at the
bottom of the Z and B helices also showed CSPs (shown as
gray sticks in Figure 5A). This has also been observed upon
titration of peptides into the BRPF1 bromodomain and may be
due to small conformational changes in the protein upon ligand
binding.23
Mapping Histone H3 K14ac Peptide Binding. BAZ2B is
reported to bind a 22-mer histone H3 peptide acetylated at
lysine 14.8 As docking programs usually fail to correctly model
long, flexible molecules, we synthesized a shorter peptide,
Peptide 1, comprised of residues 11−19 of histone H3K14ac.
We verified the binding of both peptides to BAZ2B and
determined binding constants using ITC. Peptide 1 binds to
the BAZ2B bromodomain with a KD of 45.0 ± 3.3 μM, while
the reported Peptide 2 (H3K14ac residues 6−26, +Y-tag) has a
slightly higher affinity, 12.2 ± 0.5 μM (Supplementary Table
2), consistent with the previously reported value.8
Interacting residues were characterized by measuring 2D
[15N−1H] HSQC spectra of the peptides in complex with
labeled BAZ2B bromodomain (Supplementary Figure 4).
Multiple concentration dependent effects were observed in
the protein spectra upon peptide titration, namely, chemical
shift perturbation (CSP, typical for fast exchange) and peaks
decreasing in intensity and peaks appearing in the spectra
(typical for slow exchange), indicative of an intermediate
exchange regime. CSPs and changes in peak intensity were
analyzed as described in the Experimental Procedures. Both
peptides showed binding to the same region of the protein, yet
few additional residues were affected by titration with Peptide 2
compared to Peptide 1, despite it being significantly longer
(Figure 6B,C). This observation suggests that both peptides
bind with a similar binding mode. More importantly the
additional N- and C-terminal residues on the Peptide 2 seem to
make few specific contacts with the protein, suggesting that the
key binding interactions are encapsulated by Peptide 1 alone,
consistent with the relatively small difference in binding affinity
between the two peptides.
CLEANEX-PM Experiments. It is known that the BAZ2B
bromodomain contains an important network of structural
water molecules buried in the Kac binding site. These waters
mediate the interaction with Kac and small molecules (Figure
Figure 4. Dynamics of the BAZ2B bromodomain. (A) Experimentally
derived dynamics for residues in BAZ2B. Residues with fast (ns−ps)
dynamics, shown as red sticks, lie in the ZA and BC loops, or flank
these regions. Residues with slow dynamics (μs−ms), shown as blue
sticks, reside on the B and C helices. (B) Plot of average RMSF per
residue of the BAZ2B bromodomain backbone throughout a 225 ns
molecular dynamics simulation. Regions found to display fast internal
dynamics by NMR are highlighted in gray.
Figure 5. Small molecule HSQC titration. (A) Residues showing significant CSPs upon titration of Compound 1 shown as sticks on X-ray structure
(PBD 4NRC),7 those in the binding site shown in magenta, others shown in gray. (B) Region of the 2D [15N−1H]-HSQC spectra of BAZ2B
bromodomain alone (black), with 1 mM Compound 1 (cyan) and 2 mM Compound 1 (magenta). Structure of Compound 1 shown in inset.
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1B) and are conserved.1 Accordingly they should exchange
slowly with the bulk water on the NMR time scale, making
them difficult to detect. However, recent simulations by Huang
et al.24 indicate that some of these waters are less tightly bound
in the BAZ2B bromodomain and may be able to exchange
more rapidly with the bulk solvent and be displaced by a second
postulated Kac binding mode.25 Waters in neighboring regions
of the protein should also be detectable. Observing their
displacement upon ligand binding may give insight into ligand
binding scenarios. It is challenging to obtain bound water
signals by NMR directly, and therefore we used an indirect
method, Phase-Modulated CLEAN chemical EXchange
(CLEANEX-PM) experiment26 to identify amide protons
chemically exchanging with water. In order to examine the
change in solvation in the apo and holo forms of BAZ2B, we
performed measurements in the presence and absence of
Peptide 1.
In both spectra the residues at the N- and C-termini have
proton exchange contributions (Figure 7) verifying the possible
lack of structured elements in these regions in solution.
The backbone amide of conserved Kac binding site residue
Y1901 (Figure 1B) stops exchanging with water upon addition
of Peptide 1. A side chain amide resonance also disappears.
Comparison of the X-ray crystal structures of apo (PDB 3G0L)
and Kac bound (PDB 4NR97) BAZ2B bromodomain shows
that the carbonyl oxygen of Kac displaces water bound to
N1944 side chain from the binding site (Figure 1B), consistent
with this CLEANEX-PM result. No peaks are detectable for
residues at the base of the Kac binding site, where the
conserved structural waters reside, indicating that these waters
do not exchange on the time scale of the experiment.
Interestingly backbone amides in the BC loop (E1945,
D1946, D1947) stop exchanging with water once the H3
peptide is bound (Figure 7). This may be due to either
displacement of waters by the peptide or by the peptide
forming stable water-mediated interactions that significantly
reduce exchange rates (e.g., H-bond formation). Taken
together the CSPs and CLEANEX-PM data indicate the Kac
binding site and BC loop as hotspots for binding to the histone
H3 tail.
Modeling the Complex Using HADDOCK. The structure
of the BAZ2B−Peptide 1 complex was modeled using
HADDOCK.27 Experimental data from our NMR HSQC
titrations, and the geometry of acetyl lysine and conserved
waters mediating the interaction in the binding site from X-ray
crystallography were used to generate distance restraints to
drive the docking simulation (see Experimental Procedures).
The protein-peptide docking protocol requires specific
modifications to accommodate the higher flexibility of the
peptide molecule. Therefore, we made minor adaptations to the
protocol described by Trellet et al.,17 based on observations of
different crystallized bromodomain−peptide complexes.
Figure 6. Peptide HSQC titration. (A) Plot of chemical shift perturbations observed upon titration of Peptide 1 or 2 (1:1.2 molar ratio, fractional
occupancy 0.93 and 0.84, respectively). (B) Residues affected by peptide titration mapped onto the apo protein surface. (C) Residues shifting in both
experiments mapped onto the protein surface, colored red. Residues that show shifts in the Peptide 2 titration but not in the peptide 1 titration are
colored green. Kac binding site is highlighted with a circle.
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Namely, the input ensemble consisted of the peptide in two
conformationsextended β-sheet and U-turn. Alpha helix and
Polypro conformations were excluded as preliminary runs
showed that no complex structures derived from these
progressed through to IT1, and the H3 histone tail has not
been reported to adopt either conformation. After docking and
water refinement, the four highest scored structures from the
top four clusters were analyzed (Figure 8, for the cluster
statistics of the run, see Supplementary Table 3).
All models generated place the C-termini of the peptide
between the αA and αB helices. The basic residues R17 or K18
are positioned such that they interact with the acidic residues
(E1945 and D1946) from the BC loop and the peptide lies in
the groove between the ZA loop and the αB-helix. The four top
scoring clusters show diverse arrangements for the N-terminal
portion of the peptide (residues 10−13), with different models
placing it close to the ZA loop, the BC loop, and oriented away
from the protein toward the solvent (Figure 8A). This indicates
this region of the peptide may not form any specific anchoring
interactions with the bromodomain.
Besides the visual examination of individual models, the
averaged per-residue interaction energies of the protein and
peptide over the ensemble of docked structures were plotted
(Figure 8B). Residues with the largest interaction energies in
the peptide were K14ac, R17, and K18. Although R17 and K18
have a larger contribution to binding than K14ac in the scoring,
it is known that nonacetylated H3 does not interact with the
BAZ2B bromodomain.1 Residues making favorable interactions
in the protein are those in the Kac binding site (e.g., residues
1941−1944) and in and close to the BC loop (residues 1945−
1949), consistent with the input CSP data.
Model Validation. In order to validate the docking
predictions and gain further insight into the structural
determinants of the molecular recognition, residues surround-
ing the Kac binding pocket were mutated. Folding and stability
were verified for the mutants using CD spectroscopy and
thermal melting experiments (Table 1). Mutations were well
tolerated at most sites, minimal changes in helicity observed
indicate that the mutant proteins are correctly folded. The
protein melting temperature (Tm) was only affected signifi-
cantly for mutation W1887F, whose melting temperature
nevertheless remained above 45 °C.
ITC was used to test which mutations were able to perturb
the interaction between the BAZ2B bromodomain and Peptide
2 (Table 1 and Supplementary Table 4). As expected, mutation
of V1893 or I1950 to alanine, which are in close proximity to
the acetylated lysine, caused a significant 6-fold reduction in
binding. Mutation of F1943 had the largest effect on binding.
When mutated to a more hydrophobic and bulky leucine
residue the affinity was significantly weakened, and after
mutation to alanine binding was no longer detectable,
indicating that this phenylalanine may be involved in the
Figure 7. CLEANEX-PM spectra of BAZ2B bromodomain (A) alone and (B) in the presence of Peptide 1. (C) Residues for which signals in the
CLEANEX experiment disappear upon addition of Peptide 1, shown as red sticks.
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interaction or may stabilize the required local pocket structure.
This is consistent with docked structures placing the peptide in
the groove between the B-helix and ZA loop. Mutation of
W1887 to alanine in the ZA loop did not affect the binding
interaction, consistent with NMR titrations, and in support of
HADDOCK models that do not place the peptide in this
region. Interestingly mutation of V1898 to alanine also did not
affect binding despite NMR CSP data indicating an interaction
with Peptide 2 but not Peptide 1 (Figure 6A). Therefore, we
propose that contacts may be present between the H3 peptide
and this valine side chain, but these interactions are not
contributing significantly to the binding affinity.
Peptide Binding. The HADDOCK docking results
proposed highly scoring models in which either the peptide’s
residue K18 (e.g., cluster 1, model 1) or R17 (e.g., cluster 1,
model 2) make key interactions with BC loop residues. These
residues make similar and significant contributions to the
predicted binding energy over the ensemble (Figure 8B). In
order to distinguish the importance of these residues, the
affinities of a number of H3K14ac peptides of varying length
(Peptides 1−7) were measured using ITC (Table 2 and
Supplementary Table 5).
Peptide 2 and Peptide 3 have very similar KD’s, indicating
that no interaction occurs between BAZ2B and H3 residues
more than five amino acids away from K14ac. Removal of Q19
(Peptide 4) has little consequence on binding affinity. Removal
of either K9 or K18 (Peptides 1 and 6) led to a 2-fold reduction
in affinity relative to Peptide 4. This relatively small effect is not
additive, as Peptide 5, where both K9 and K18 are not present,
has a similar KD. This implies K18 is not a key driver of the
additional affinity of H3K14ac for BAZ2B. No heats were
observed upon titration of 2.4 mM Peptide 7 into 100 μM
BAZ2B bromodomain, indicating that the KD is >2 mM. These
results identify R17 as a key determinant of binding and
validate HADDOCK models in which R17 makes a large
contribution to the binding interactions (Figure 9).
■ DISCUSSION
We have assigned the backbone resonances in the BAZ2B
bromodomain 15N−1H HSQC spectra and characterized the
protein dynamics using NMR spectroscopy and molecular
dynamics simulations, revealing a relatively rigid bromodomain
in solution. CSPs mapping was validated by titration of a small
molecule ligands for which the binding mode has been
independently verified. These assignments therefore also
provide a useful platform for screening and binding site
elucidation of small molecules. In order to provide new
chemical tools to uncover the biological role of the BAZ2B
bromodomain, a number of compounds have been developed
to inhibit its interaction with histones.7,28 Thus far, ligands
predominantly target the small Kac binding site. Identification
of additional binding hotspots provides new insights that may
Figure 8. Results of HADDOCK docking (A) Overlay of the top scored models from the top four clusters. (B) Per residue interaction energy (sum
of van der Waals and electrostatic energies) for interacting residues in the protein (blue) and peptide (red). Values are shown as an average over the
ensemble of output HADDOCK poses.
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aid future efforts to generate novel selective chemical probes for
this bromodomain.
Interestingly we observed an intermediate exchange regime
for two H3K14ac peptides, although one of their KD’s falls
within a range that should be under a fast exchange regime
(Peptide 1, 45.0 ± 3.3 μM). The relatively different
contributions to affinity of peptide residues may explain
peaks appearing/disappearing; e.g., the BC loop residues
D1945 and E1946 consistently show significantly reduced
intensity in both titrations. Interestingly the BAZ2 bromodo-
mains are the only ones in the family to contain three
sequential acidic residues in their BC loop,1 and we observed
that this patch is indeed involved in the interaction. The data
consistently highlight the BC loop as a key hotspot for
interaction with H3 peptides, in addition to the Kac binding
site. Residue R17 on histone H3 was found to be the crucial
additional interacting residue of H3, conferring affinity to the
interaction. Mutagenesis data also highlighted F1943 as an
important residue for binding.
Water molecules play an important role in bromodomain−
ligand interactions. For the first time we have monitored
changes in water exchange rates upon peptide binding in a
bromodomain using CLEANEX-PM experiments, in a
qualitative manner. These experiments re-enforced the
involvement of the BC loop in H3 peptide recognition
consistent with the binding mode of the modeled peptide.
There has been much recent interest in the water molecules
at the bottom of the bromodomain Kac binding pocket from a
drug design standpoint.24,25 Key questions are to what extent
they are displaceable and whether a small molecule should be
designed to hydrogen bond to them or to displace them and
form the same interactions as the waters do.24,29 Thus far, this
question has only been addressed using MD simulations.
Extension of the CLEANEX-PM experiments to observe
different exchange rates may provide additional insight into
which waters in this pocket are stable and how this differs
between different bromodomains.
In conclusion, the key determinants for the BAZ2B/
H3K14ac peptide interaction have been elucidated using a
combination of biophysical and computational techniques.
Such an approach allowed us to characterize both protein and
Table 1. Melting Temperatures of Wildtype and Point
Mutants of BAZ2B Bromodomain As Average of Three
Replicatesa
protein Tm (°C) ΔTm vs WT % α-helix KD (μM)
F1943A 53.3 1.0 60
WT 52.3 0.0 60 12.2 ± 0.5
I1950A 52.2 −0.1 57 64.0 ± 4.1
V1893A 51.3 −1.0 57 66.6 ± 3.7
V1898A 51.3 −1.0 57 9.1 ± 1.0
F1943L 50.2 −2.1 60 127.7 ± 7.8
W1887H 49.3 −3.0 61 16.8 ± 1.2
W1887F 45.2 −7.1 60 10.6 ± 0.2
aNo variation in Tm was observed between replicates. % α-Helix from
CD measurements calculated according to Correâ et al.32 Binding
affinities of BAZ2B bromodomain mutants for Peptide 2 measured
using ITC.
Table 2. Binding Affinities of H3K14ac Peptides for BAZ2B Bromodomain
peptide no. peptide sequence KD (μM)
1 Ac-STGGK(ac)APRK-NH2 45.0 ± 3.3
2 Ac-YQTARKSTGGK(Ac)APRKQLATKAK-NH2 12.2 ± 0.5
3 Ac-KSTGGK(ac)APRKQ-NH2 15.7 ± 1.1
4 Ac-KSTGGK(ac)APRK-NH2 21.8 ± 1.4
5 Ac-STGGK(ac)APR-NH2 52.4 ± 2.4
6 Ac-KSTGGK(ac)APR-NH2 37.6 ± 2.1
7 Ac-KSTGGK(ac)AP-NH2 >2000
Figure 9. (A) Surface view of the HADDOCK model of the BAZ2B/
Peptide 1 complex in closest agreement with experimental data.
Residues with CSPs upon titration of Peptide 1 are colored blue. (B)
Alternate view of the HADDOCK model, BAZ2B shown gray,
interacting residues shown as sticks, H-bonds shown as red dashed
lines.
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peptide contributions and provide structural insights into the
molecular recognition. This strategy is generally applicable to
many bromodomain−peptide interactions and provides a
convenient alternative to structure determination by NOE-
based NMR or X-ray crystallography in challenging cases where
the acetylated interacting partner has a relatively weak affinity
(high micromolar to millimolar) for the bromodomain, as is the
case for many of the reported histone−bromodomain
interactions30 for which there are no currently available
structures (e.g., BRD7:H3K14ac, KD 1.9 mM
31).
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